venetoclax FDA approval date

The FDA approved venetoclax on 11 Apr 2016.

FDA approval date
11 Apr 2016

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesNCT07520006NRIXPhase 1, Phase 2Recruiting2033-05Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-04-11DayvenetoclaxFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208573", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VENCLEXTA"], "active_ingredients": ["VENETOCLAX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160411", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 26 Oct 2026 · Evidence last checked: 26 Oct 2026